Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rhythm Pharmaceuticals (RYTM) Debt Ratio: 2016-2025

Historic Debt Ratio for Rhythm Pharmaceuticals (RYTM) over the last 1 years, with Sep 2025 value amounting to 0.21.

  • Rhythm Pharmaceuticals' Debt Ratio was N/A to 0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.21, marking a year-over-year change of. This contributed to the annual value of 0.28 for FY2024, which is 12.24% down from last year.
  • Latest data reveals that Rhythm Pharmaceuticals reported Debt Ratio of 0.21 as of Q3 2025, which was down 27.02% from 0.29 recorded in Q2 2025.
  • Over the past 5 years, Rhythm Pharmaceuticals' Debt Ratio peaked at 0.32 during Q4 2023, and registered a low of 0.21 during Q3 2025.
  • Over the past 3 years, Rhythm Pharmaceuticals' median Debt Ratio value was 0.28 (recorded in 2025), while the average stood at 0.28.
  • Data for Rhythm Pharmaceuticals' Debt Ratio shows a maximum YoY decreased of 12.24% (in 2024) over the last 5 years.
  • Rhythm Pharmaceuticals' Debt Ratio (Quarterly) stood at 0.32 in 2023, then fell by 12.24% to 0.28 in 2024, then reached 0.21 in 2025.
  • Its Debt Ratio stands at 0.21 for Q3 2025, versus 0.29 for Q2 2025 and 0.28 for Q1 2025.